These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 24466548

  • 1. Comparison of laboratory characteristics between acute promyelocytic leukemia and other subtypes of acute myeloid leukemia with disseminated intravascular coagulation.
    Lee HJ, Park HJ, Kim HW, Park SG.
    Blood Res; 2013 Dec; 48(4):250-3. PubMed ID: 24466548
    [Abstract] [Full Text] [Related]

  • 2. Management of Disseminated Intravascular Coagulation in Acute Leukemias.
    Ten Cate H, Leader A.
    Hamostaseologie; 2021 Apr; 41(2):120-126. PubMed ID: 33860520
    [Abstract] [Full Text] [Related]

  • 3. A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia.
    Shahmarvand N, Oak JS, Cascio MJ, Alcasid M, Goodman E, Medeiros BC, Arber DA, Zehnder JL, Ohgami RS.
    Int J Lab Hematol; 2017 Aug; 39(4):375-383. PubMed ID: 28422420
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.
    Ookura M, Hosono N, Tasaki T, Oiwa K, Fujita K, Ito K, Lee S, Matsuda Y, Morita M, Tai K, Negoro E, Kishi S, Iwasaki H, Ueda T, Yamauchi T.
    Medicine (Baltimore); 2018 Nov; 97(44):e12981. PubMed ID: 30383650
    [Abstract] [Full Text] [Related]

  • 5. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H, Zhu CY, Wang QS, Niu JH, Zhang Q, Zhu HY, Yao ZL, Xu YY, Jing Y, Yu L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
    [Abstract] [Full Text] [Related]

  • 6. [Clinical evaluation of Chinese disseminated intravascular coagulation scoring system (version 2017) in patients with acute promyelocytic leukemia].
    Huang YT, Liu XF, Fu RF, Chen YF, Liu W, Xue F, Zhang L, Yang RC.
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jun 14; 39(6):480-484. PubMed ID: 30032565
    [Abstract] [Full Text] [Related]

  • 7. Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia.
    Li S, Gao Y, Li F, Zheng Y, Su Y.
    Ann Hematol; 2023 Apr 14; 102(4):787-794. PubMed ID: 36750485
    [Abstract] [Full Text] [Related]

  • 8. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH, Kim DH, Lee JS, Suh CW, Kim SW, Kim SB, Lee JH, Doh BS, Chi HS, Lee MS.
    J Korean Med Sci; 1994 Dec 14; 9(6):437-43. PubMed ID: 7786438
    [Abstract] [Full Text] [Related]

  • 9. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H, Scrobohaci ML, Ghorra P, Zini JM, Daniel MT, Castaigne S, Degos L.
    Leukemia; 1993 Jan 14; 7(1):2-9. PubMed ID: 8418375
    [Abstract] [Full Text] [Related]

  • 10. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
    Okumura N, Furuwatari C, Ishikawa S, Furihata K, Katsuyama T, Kanai M, Nakahata T, Saitoh H.
    Rinsho Byori; 1993 Jun 14; 41(6):719-25. PubMed ID: 8361040
    [Abstract] [Full Text] [Related]

  • 11. Blood Parameters in Treatment with Arsenic Trioxide in Acute Promyelocytic Leukemia: A Systematic Review.
    Mohammadi Kanesbi M, Jarahi L, Keramati MR.
    Int J Hematol Oncol Stem Cell Res; 2020 Apr 01; 14(2):130-139. PubMed ID: 32461798
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 Apr 01; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 15. The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study.
    Baysal M, Gürsoy V, Hunutlu FC, Erkan B, Demirci U, Bas V, Gulsaran SK, Pinar IE, Ersal T, Kirkizlar TA, Atli EI, Kirkizlar HO, Ümit EG, Gürkan H, Ozkocaman V, Ozkalemkas F, Demir AM, Ali R.
    Ann Hematol; 2022 May 01; 101(5):1049-1057. PubMed ID: 35190843
    [Abstract] [Full Text] [Related]

  • 16. Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
    Kawano N, Kuriyama T, Yoshida S, Yamashita K, Ochiai H, Nakazaki S, Tasaki A, Ueda A.
    Intern Med; 2013 May 01; 52(1):55-62. PubMed ID: 23291674
    [Abstract] [Full Text] [Related]

  • 17. Acute promyelocytic leukemia presenting as a paraspinal mass.
    Shah NN, Stonecypher M, Gopal P, Luger S, Bagg A, Perl A.
    J Community Support Oncol; 2016 Mar 01; 14(3):126-9. PubMed ID: 27058871
    [Abstract] [Full Text] [Related]

  • 18. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
    Chang H, Kuo MC, Shih LY, Dunn P, Wang PN, Wu JH, Lin TL, Hung YS, Tang TC.
    Eur J Haematol; 2012 Apr 01; 88(4):321-8. PubMed ID: 22221178
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the fibrinolytic state by measuring stable cross-linked fibrin degradation products in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
    Okajima K, Koga S, Okabe H, Inoue M, Takatsuki K.
    Acta Haematol; 1989 Apr 01; 81(1):15-8. PubMed ID: 2494830
    [Abstract] [Full Text] [Related]

  • 20. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T, Watanabe J, Honda G, Mimuro J, Takahashi H, Tsuji H, Eguchi Y, Kitajima I, Sakata Y.
    Thromb Res; 2014 May 01; 133(5):772-81. PubMed ID: 24636871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.